TRDA
Baker Bros. Advisors Lp, TRDA's 10% owner, spent $625.3K of their own money on 80,881 shares at $8, growing their stake 2%.
+$625.3K
80,881 sh @ $8
TRDA
Entrada Therapeutics, Inc.
SEC CIK 1689375
$6.46
−40.3% · 90 days
90-day buys
$29.3K
1 open-market
90-day sells
$661.1K
3 open-market
Net insider flow
−$631.8K
Net selling
Filings shown
67
Most recent
Advertisement
At a glance
Over the last 90 days, insiders at TRDA have sold a net $631.8K of stock (1 open-market buy vs 3 sells).
Largest recent trade: Mpm Bioventures 2018, L.p., TRDA's 10% owner, spent $2M of their own money on 100,000 shares at $20, growing their stake 2%.
Most active filer: Baker Bros. Advisors Lp, with 16 transactions among the recent filings shown.
Insider transaction history
Form 4 filings for TRDA, newest firstTRDA
Baker Bros. Advisors Lp, TRDA's 10% owner, spent $8.3K of their own money on 1,040 shares at $8.
+$8.3K
1,040 sh @ $8
TRDA
Baker Bros. Advisors Lp, TRDA's 10% owner, spent $91.4K of their own money on 11,494 shares at $8.
+$91.4K
11,494 sh @ $8
TRDA
Baker Bros. Advisors Lp, TRDA's 10% owner, spent $7.8K of their own money on 1,059 shares at $7.
+$7.8K
1,059 sh @ $7
TRDA
Baker Bros. Advisors Lp, TRDA's 10% owner, spent $86.5K of their own money on 11,701 shares at $7.
+$86.5K
11,701 sh @ $7
Advertisement
TRDA
Baker Bros. Advisors Lp, TRDA's 10% owner, spent $21.1K of their own money on 2,795 shares at $8, growing their stake 1%.
+$21.1K
2,795 sh @ $8
TRDA
Baker Bros. Advisors Lp, TRDA's 10% owner, spent $232.8K of their own money on 30,879 shares at $8, growing their stake 1%.
+$232.8K
30,879 sh @ $8
TRDA
Baker Bros. Advisors Lp, TRDA's 10% owner, spent $16.6K of their own money on 2,296 shares at $7, growing their stake 1%.
+$16.6K
2,296 sh @ $7
TRDA
Baker Bros. Advisors Lp, TRDA's 10% owner, spent $183K of their own money on 25,364 shares at $7, growing their stake 1%.
+$183K
25,364 sh @ $7
TRDA
Baker Bros. Advisors Lp, TRDA's 10% owner, spent $1.9K of their own money on 267 shares at $7.
+$1.9K
267 sh @ $7
TRDA
Baker Bros. Advisors Lp, TRDA's 10% owner, spent $21.3K of their own money on 2,947 shares at $7.
+$21.3K
2,947 sh @ $7
TRDA
−$47.4K
8,723 sh @ $5
TRDA
−$9.5K
1,746 sh @ $5
TRDA
−$9.6K
1,760 sh @ $5
TRDA
−$9.4K
1,734 sh @ $5
TRDA
−$150.5K
20,065 sh @ $8
TRDA
−$52K
6,935 sh @ $8
TRDA
−$150.5K
20,065 sh @ $8
TRDA
−$52K
6,935 sh @ $8
TRDA
−$132.3K
18,578 sh @ $7
TRDA
−$45.7K
6,422 sh @ $7
TRDA
−$132.3K
18,578 sh @ $7
TRDA
−$45.7K
6,422 sh @ $7
TRDA
−$126.6K
18,578 sh @ $7
TRDA
−$43.8K
6,422 sh @ $7
TRDA
−$126.6K
18,578 sh @ $7
TRDA
−$43.8K
6,422 sh @ $7
TRDA
−$385.1K
55,735 sh @ $7
TRDA
−$133.1K
19,265 sh @ $7
TRDA
−$385.1K
55,735 sh @ $7
Advertisement
About TRDA insider activity
This page tracks every recent Form 4 filed for Entrada Therapeutics, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.
The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.
Frequently asked questions
How often is TRDA insider data updated?
Continuously. We read from SEC EDGAR, so new Form 4 filings for Entrada Therapeutics, Inc. usually appear here within minutes of being accepted by the SEC.
What does "net insider flow" mean?
It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.
Why do some rows show grants or option exercises instead of buys?
Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.
Is this investment advice?
No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.